Correlation Between CannaGlobal Acquisition and Spyre Therapeutics

Can any of the company-specific risk be diversified away by investing in both CannaGlobal Acquisition and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CannaGlobal Acquisition and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CannaGlobal Acquisition Corp and Spyre Therapeutics, you can compare the effects of market volatilities on CannaGlobal Acquisition and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CannaGlobal Acquisition with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CannaGlobal Acquisition and Spyre Therapeutics.

Diversification Opportunities for CannaGlobal Acquisition and Spyre Therapeutics

0.0

Correlation Coefficient

CannaGlobal Acquisition  Spyre Therapeutics

Pay attention - limited upside

The 3 months correlation between CannaGlobal and Spyre is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CannaGlobal Acquisition Corp and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and CannaGlobal Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CannaGlobal Acquisition Corp are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of CannaGlobal Acquisition i.e., CannaGlobal Acquisition and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between CannaGlobal Acquisition and Spyre Therapeutics

If you would invest (100.00) in CannaGlobal Acquisition Corp on December 30, 2024 and sell it today you would earn a total of  100.00  from holding CannaGlobal Acquisition Corp or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

CannaGlobal Acquisition Corp  vs.  Spyre Therapeutics

CannaGlobal Acquisition

Risk-Adjusted Performance

Very Weak

Over the last 90 days CannaGlobal Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, CannaGlobal Acquisition is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Spyre Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with CannaGlobal Acquisition and Spyre Therapeutics

The main advantage of trading using opposite CannaGlobal Acquisition and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CannaGlobal Acquisition position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.

The idea behind CannaGlobal Acquisition Corp and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.